Journal of pharmaceutical sciences

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics.

Journal of pharmaceutical sciences

Wacher VJ, Silverman JA, Zhang Y, Benet LZ

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics.

Journal of pharmaceutical sciences

Wacher VJ, Silverman JA, Zhang Y, Benet LZ

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

Journal of pharmaceutical sciences

Peck CC, Barr WH, Benet LZ, Collins J, Desjardins RE, Furst DE, Harter JG, Levy G, Ludden T, Rodman JH

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

Journal of pharmaceutical sciences

Peck CC, Barr WH, Benet LZ, Collins J, Desjardins RE, Furst DE, Harter JG, Levy G, Ludden T, Rodman JH

Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms.

Journal of pharmaceutical sciences

Skelley JP, Amidon GL, Barr WH, Benet LZ, Carter JE, Robinson JR, Shah VP, Yacobi A

Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms.

Journal of pharmaceutical sciences

Skelley JP, Amidon GL, Barr WH, Benet LZ, Carter JE, Robinson JR, Shah VP, Yacobi A

Pages